8. Obesity Management for the Treatment of Type 2 Diabetes:Standards of Medical Care in Diabetes—2020
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc20-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc20-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934 · cited 1×
“gery maintain substantial improvement of glycemic control from baseline for at least 5 years (74,75) to 15 years (51,52,73,76–78).”
BackgroundCardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
DONNELLY, J. E., BLAIR, S. N., JAKICIC, J. M., MANORE, M. M., RANKIN, J. W., & SMITH, B. K. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181949333 · Cited by 2,658
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 1×
“Greater weight loss produces even greater benefits, including reductions in blood pressure, improvements in LDL and HDL cholesterol, and reductions in the need formedications to control blood glucose, blood pressure, and lipids (6–8,28), and may result in achievement of glycemic goals in the absence of glucose-lowerin…”
BackgroundComparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Sacks, F. M., Bray, G. A., Carey, V. J., Smith, S. R., Ryan, D. H., Anton, S. D., McManus, K., Champagne, C. M., Bishop, L. M., Laranjo, N., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804748 · Cited by 1,966
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Brethauer, S. A., Navaneethan, S. D., Aminian, A., Pothier, C. E., Kim, E. S. H., Nissen, S. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401329 · Cited by 1,901
Surgical skill and complication rates after bariatric surgery
Birkmeyer, J. D., Finks, J. F., O'Reilly, A., Oerline, M., Carlin, A. M., Nunn, A. R., Dimick, J., Banerjee, M., & Birkmeyer, N. J. O. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1300625 · Cited by 1,504
Perioperative safety in the longitudinal assessment of bariatric surgery
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901836 · Cited by 1,392
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., Castagneto, M., Bornstein, S., & Rubino, F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00075-6 · Cited by 1,220
Davies, M. J., Bergenstal, R., Bode, B., Kushner, R. F., Lewin, A., Skjøth, T. V., Andreasen, A. H., Jensen, C. B., DeFronzo, R. A., & for the NN8022-1922 Study Group (2015) · JAMA · doi:10.1001/jama.2015.9676 · Cited by 1,198
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164
Gadde, K. M., Allison, D. B., Ryan, D. H., Peterson, C. A., Troupin, B., Schwiers, M. L., & Day, W. W. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60205-5 · Cited by 1,064
Sjöström, L., Peltonen, M., Jacobson, P., Ahlin, S., Andersson-Assarsson, J., Anveden, Å., Bouchard, C., Carlsson, B., Karason, K., Lönroth, H., et al. (2014) · JAMA · doi:10.1001/jama.2014.5988 · Cited by 1,054 · cited 1×
“, ,8 years) (79), nonuse of insulin, maintenance of weight loss, and better glycemic control are consistently associated with higher rates of diabetes remission and/or lower risk of weight regain (51,77,79,80).”
BackgroundLean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 1,017 · cited 1×
“Greater weight loss produces even greater benefits, including reductions in blood pressure, improvements in LDL and HDL cholesterol, and reductions in the need formedications to control blood glucose, blood pressure, and lipids (6–8,28), and may result in achievement of glycemic goals in the absence of glucose-lowerin…”
BackgroundRubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., Herman, W. H., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0236 · Cited by 1,008
le Roux, C. W., Astrup, A., Fujioka, K., Greenway, F., Lau, D. C. W., Van Gaal, L., Ortiz, R. V., Wilding, J. P. H., Skjøth, T. V., Manning, L. S., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30069-7 · Cited by 850
Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study
The Look AHEAD Research Group (2014) · Obesity · doi:10.1002/oby.20662 · Cited by 842
Courcoulas, A. P. (2013) · JAMA · doi:10.1001/jama.2013.280928 · Cited by 799
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Service, G. J., Thompson, G. B., Service, F. J., Andrews, J. C., Collazo-Clavell, M. L., & Lloyd, R. V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043690 · Cited by 779
Sjöström, L., Gummesson, A., Sjöström, C. D., Narbro, K., Peltonen, M., Wedel, H., Bengtsson, C., Bouchard, C., Carlsson, B., Dahlgren, S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70159-7 · Cited by 770
Courcoulas, A. P., King, W. C., Belle, S. H., Berk, P., Flum, D. R., Garcia, L., Gourash, W., Horlick, M., Mitchell, J. E., Pomp, A., et al. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2017.5025 · Cited by 699
Hutter, M. M., Schirmer, B. D., Jones, D. B., Ko, C. Y., Cohen, M. E., Merkow, R. P., & Nguyen, N. T. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31822c9dac · Cited by 673
Franz, M. J., Boucher, J. L., Rutten-Ramos, S., & VanWormer, J. J. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2015.02.031 · Cited by 672
Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Day, J. W., Ottaway, N., Patterson, J. T., Gelfanov, V., Smiley, D., Gidda, J., Findeisen, H., Bruemmer, D., Drucker, D. J., Chaudhary, N., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.209 · Cited by 641
Hollander, P., Gupta, A. K., Plodkowski, R., Greenway, F., Bays, H., Burns, C., Klassen, P., Fujioka, K., & for the COR-Diabetes Study Group (2013) · Diabetes Care · doi:10.2337/dc13-0234 · Cited by 501
The evidence for the effectiveness of medical nutrition therapy in diabetes management
Pastors, J. G., Warshaw, H., Daly, A., Franz, M., & Kulkarni, K. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.608 · Cited by 434
Arterburn, D. E., Bogart, A., Sherwood, N. E., Sidney, S., Coleman, K. J., Haneuse, S., O’Connor, P. J., Theis, M. K., Campos, G. M., McCulloch, D., et al. (2013) · Obesity Surgery · doi:10.1007/s11695-012-0802-1 · Cited by 426
Steven, S., Hollingsworth, K. G., Al-Mrabeh, A., Avery, L., Aribisala, B., Caslake, M., & Taylor, R. (2016) · Diabetes Care · doi:10.2337/dc15-1942 · Cited by 418 · cited 1×
“0 mmol/L) in the absence of pharmacologic therapy or ongoing procedures (10,18,19).”
BackgroundThe Evolution of Very‐Low‐Calorie Diets: An Update and Meta‐analysis
Tsai, A. G., & Wadden, T. A. (2006) · Obesity · doi:10.1038/oby.2006.146 · Cited by 371
Jakobsen, G. S., Småstuen, M. C., Sandbu, R., Nordstrand, N., Hofsø, D., Lindberg, M., Hertel, J. K., & Hjelmesæth, J. (2018) · JAMA · doi:10.1001/jama.2017.21055 · Cited by 358
Efficacy of Commercial Weight-Loss Programs: An Updated Systematic Review
Gudzune, K. A., Doshi, R. S., Mehta, A. K., Chaudhry, Z. W., Jacobs, D. K., Vakil, R. M., Lee, C. J., Bleich, S. N., & Clark, J. M. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2238 · Cited by 325
Rubino, F., Kaplan, L. M., Schauer, P. R., & Cummings, D. E. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181be34e7 · Cited by 325
The importance of weight management in type 2 diabetes mellitus
Wilding, J. P. H. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12384 · Cited by 314 · cited 2×
“Secondary analyses of the Look AHEAD trial and other large cardiovascular outcome studies document other benefits of weight loss in patients with type 2 diabetes, including improvements in mobility, physical and sexual function, and health-related quality of life (23).”
BackgroundMethodFisher, D. P., Johnson, E., Haneuse, S., Arterburn, D., Coleman, K. J., O’Connor, P. J., O’Brien, R., Bogart, A., Theis, M. K., Anau, J., et al. (2018) · JAMA · doi:10.1001/jama.2018.14619 · Cited by 305
Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity
Cohen, R. V., Pinheiro, J. C., Schiavon, C. A., Salles, J. E., Wajchenberg, B. L., & Cummings, D. E. (2012) · Diabetes Care · doi:10.2337/dc11-2289 · Cited by 282
Aronne, L. J., Wadden, T. A., Peterson, C., Winslow, D., Odeh, S., & Gadde, K. M. (2013) · Obesity · doi:10.1002/oby.20584 · Cited by 274
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Bohula, E. A., Wiviott, S. D., McGuire, D. K., Inzucchi, S. E., Kuder, J., Im, K., Fanola, C. L., Qamar, A., Brown, C., Budaj, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1808721 · Cited by 265
Nguyen, N. T., Slone, J. A., Nguyen, X.-M. T., Hartman, J. S., & Hoyt, D. B. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b92480 · Cited by 255
Johansson, K., Neovius, M., & Hemmingsson, E. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.070052 · Cited by 243
Weight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment
Van Gaal, L., & Scheen, A. (2015) · Diabetes Care · doi:10.2337/dc14-1630 · Cited by 221 · cited 1×
“for concerns, and the need for weight monitoring should be explained as a part of themedical evaluation process that helps to inform treatment decisions (23,24).”
BackgroundGarvey, W. T., Ryan, D. H., Henry, R., Bohannon, N. J. V., Toplak, H., Schwiers, M., Troupin, B., & Day, W. W. (2014) · Diabetes Care · doi:10.2337/dc13-1518 · Cited by 215
Liang, Z., Wu, Q., Chen, B., Yu, P., Zhao, H., & Ouyang, X. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.04.005 · Cited by 206
de Souza, R. J., Bray, G. A., Carey, V. J., Hall, K. D., LeBoff, M. S., Loria, C. M., Laranjo, N. M., Sacks, F. M., & Smith, S. R. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.026328 · Cited by 192
O'Brien, R., Johnson, E., Haneuse, S., Coleman, K. J., O'Connor, P. J., Fisher, D. P., Sidney, S., Bogart, A., Theis, M. K., Anau, J., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2383 · Cited by 161 · cited 1×
“Beyond improving glycemia, metabolic surgery has been shown to confer additional health benefits in randomized controlled trials, including substantial reductions in cardiovascular disease risk factors (17), reductions in incidence of microvascular disease (82), and enhancements in quality of life (74,79,83).”
BackgroundLee, C. J., Clark, J. M., Schweitzer, M., Magnuson, T., Steele, K., Koerner, O., & Brown, T. T. (2015) · Obesity · doi:10.1002/oby.21042 · Cited by 159 · cited 4×
“In one study, it affected 11% of 450 patients who had undergone RYGB or vertical sleeve gastrectomy (98).”
BackgroundInfluentialWeight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release
Garvey, W. T., Ryan, D. H., Bohannon, N. J. V., Kushner, R. F., Rueger, M., Dvorak, R. V., & Troupin, B. (2014) · Diabetes Care · doi:10.2337/dc14-0930 · Cited by 149
ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30–35 kg/m2)
Aminian, A., Chang, J., Brethauer, S. A., & Kim, J. J. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.05.025 · Cited by 106
Ikramuddin, S., Korner, J., Lee, W.-J., Bantle, J. P., Thomas, A. J., Connett, J. E., Leslie, D. B., Inabnet, W. B., Wang, Q., Jeffery, R. W., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2481 · Cited by 99
Impact of weight loss on waist circumference and the components of the metabolic syndrome
Rothberg, A. E., McEwen, L. N., Kraftson, A. T., Ajluni, N., Fowler, C. E., Nay, C. K., Miller, N. M., Burant, C. F., & Herman, W. H. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000341 · Cited by 92
Bariatric surgery in obese patients with type 1 diabetes
Kirwan, J. P., Aminian, A., Kashyap, S. R., Burguera, B., Brethauer, S. A., & Schauer, P. R. (2016) · Diabetes Care · doi:10.2337/dc15-2732 · Cited by 80
Psychosocial Care for People with Diabetes American Diabetes Association
Young-Hyman, D., & Peyrot, M. (2012) · doi:10.2337/9781580404396 · Cited by 17
Research works printed but not linked: 50
- Booth, 2014, Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study, Lancet Diabetes Endocrinol, 2, 963, 10.1016/S2213-8587(14)70214-1 · DOI · Paper page
- Goldstein, 1992, Beneficial health effects of modest weight loss, Int J Obes Relat Metab Disord, 16, 397
- Jackness, 2013, Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell function in type 2 diabetic patients, Diabetes, 62, 3027, 10.2337/db12-1762 · DOI · Paper page
- Rothberg, 2014, Very-low-energy diet for type 2 diabetes: an underutilized therapy?, J Diabetes Complications, 28, 506, 10.1016/j.jdiacomp.2014.03.014 · DOI
- O’Neil, 2012, Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study, Obesity (Silver Spring), 20, 1426, 10.1038/oby.2012.66 · DOI · Paper page
- Jensen, 2014, 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society, J Am Coll Cardiol, 63, 2985, 10.1016/j.jacc.2013.11.004 · DOI · Paper page
- Bosch, 2017, Unintentional weight loss: clinical characteristics and outcomes in a prospective cohort of 2677 patients, PLoS One, 12, e0175125, 10.1371/journal.pone.0175125 · DOI
- WHO Expert Consultation, 2004, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies, Lancet, 363, 157, 10.1016/S0140-6736(03)15268-3 · DOI · Paper page
- Araneta, 2015, Optimum BMI cut points to screen Asian Americans for type 2 diabetes, Diabetes Care, 38, 814, 10.2337/dc14-2071 · DOI
- Warren, 2016, Higher motivation for weight loss in African American than Caucasian rural patients with hypertension and/or diabetes, Ethn Dis, 26, 77, 10.18865/ed.26.1.77 · DOI
- Baum, 2017, Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial, Lancet Diabetes Endocrinol, 5, 808, 10.1016/S2213-8587(17)30176-6 · DOI
- Johnston, 2014, Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis, JAMA, 312, 923, 10.1001/jama.2014.10397 · DOI · Paper page
- Raynor, 2015, Partial meal replacement plan and quality of the diet at 1 year: Action for Health in Diabetes (Look AHEAD) trial, J Acad Nutr Diet, 115, 731, 10.1016/j.jand.2014.11.003 · DOI
- Leung, 2014, Food insecurity is inversely associated with diet quality of lower-income adults, J Acad Nutr Diet, 114, 1943, 10.1016/j.jand.2014.06.353 · DOI · Paper page
- Cai, 2016, Baseline body mass index and the efficacy of hypoglycemic treatment in type 2 diabetes: a meta-analysis, PLoS One, 11, e0166625, 10.1371/journal.pone.0166625 · DOI · Paper page
- Domecq, 2015, Clinical review: drugs commonly associated with weight change: a systematic review and meta-analysis, J Clin Endocrinol Metab, 100, 363, 10.1210/jc.2014-3421 · DOI · Paper page
- Kahan, 2017, Obesity pharmacotherapy in patients with type 2 diabetes, Diabetes Spectr, 30, 250, 10.2337/ds17-0044 · DOI
- Sullivan, 2017, Endoscopic medical devices for primary obesity treatment in patients with diabetes, Diabetes Spectr, 30, 258, 10.2337/ds017-0046 · DOI · Paper page
- Greenway, 2019, A randomized, double-blind, placebo-controlled study of gelesis100: a novel nonsystemic oral hydrogel for weight loss, Obesity (Silver Spring), 27, 205, 10.1002/oby.22347 · DOI · Paper page
- Adams, 2012, Health benefits of gastric bypass surgery after 6 years, JAMA, 308, 1122, 10.1001/2012.jama.11164 · DOI · Paper page
- Sjöström, 2012, Bariatric surgery and long-term cardiovascular events, JAMA, 307, 56, 10.1001/jama.2011.1914 · DOI · Paper page
- Arterburn, 2015, Association between bariatric surgery and long-term survival, JAMA, 313, 62, 10.1001/jama.2014.16968 · DOI · Paper page
- Adams, 2016, Clinical outcomes of metabolic surgery: microvascular and macrovascular complications, Diabetes Care, 39, 912, 10.2337/dc16-0157 · DOI
- Sheng, 2017, The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis, Obes Surg, 27, 2724, 10.1007/s11695-017-2866-4 · DOI · Paper page
- Billeter, 2018, Meta-analysis of metabolic surgery versus medical treatment for microvascular complications in patients with type 2 diabetes mellitus, Br J Surg, 105, 168, 10.1002/bjs.10724 · DOI · Paper page
- Cummings, 2014, Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery, Lancet Diabetes Endocrinol, 2, 175, 10.1016/S2213-8587(13)70198-0 · DOI
- Zimmet, 2011, IDF’s view of bariatric surgery in type 2 diabetes, Lancet, 378, 108, 10.1016/S0140-6736(11)61027-1 · DOI
- Kasama, 2012, IFSO-APC consensus statements 2011, Obes Surg, 22, 677, 10.1007/s11695-012-0610-7 · DOI · Paper page
- Wentworth, 2017, Five-year outcomes of a randomized trial of gastric band surgery in overweight but not obese people with type 2 diabetes, Diabetes Care, 40, e44, 10.2337/dc16-2149 · DOI · Paper page
- Cummings, 2016, Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial, Diabetologia, 59, 945, 10.1007/s00125-016-3903-x · DOI · Paper page
- Isaman, 2016, Reconciliation of type 2 diabetes remission rates in studies of Roux-en-Y gastric bypass, Diabetes Care, 39, 2247, 10.2337/dc16-0954 · DOI · Paper page
- Sjöholm, 2015, Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study, Diabetologia, 58, 1448, 10.1007/s00125-015-3591-y · DOI · Paper page
- Brethauer, 2013, Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus, Ann Surg, 258, 628, 10.1097/SLA.0b013e3182a5034b · DOI · Paper page
- Hsu, 2015, Effect of bariatric surgery vs medical treatment on type 2 diabetes in patients with body mass index lower than 35: five-year outcomes, JAMA Surg, 150, 1117, 10.1001/jamasurg.2015.2602 · DOI
- Hariri, 2018, Preoperative insulin therapy as a marker for type 2 diabetes remission in obese patients after bariatric surgery, Surg Obes Relat Dis, 14, 332, 10.1016/j.soard.2017.11.016 · DOI
- Yu, 2015, Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2, Surg Obes Relat Dis, 11, 6, 10.1016/j.soard.2014.06.019 · DOI
- Halperin, 2014, Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial, JAMA Surg, 149, 716, 10.1001/jamasurg.2014.514 · DOI · Paper page
- Rubin, 2016, Identifying barriers to appropriate use of metabolic/bariatric surgery for type 2 diabetes treatment: policy lab results, Diabetes Care, 39, 954, 10.2337/dc15-2781 · DOI · Paper page
- Fouse, 2016, The socioeconomic impact of morbid obesity and factors affecting access to obesity surgery, Surg Clin North Am, 96, 669, 10.1016/j.suc.2016.03.002 · DOI
- Arterburn, 2014, Bariatric surgery for obesity and metabolic conditions in adults, BMJ, 349, g3961, 10.1136/bmj.g3961 · DOI · Paper page
- Young, 2015, Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP, J Am Coll Surg, 220, 880, 10.1016/j.jamcollsurg.2015.01.059 · DOI · Paper page
- Aminian, 2015, How safe is metabolic/diabetes surgery?, Diabetes Obes Metab, 17, 198, 10.1111/dom.12405 · DOI · Paper page
- Birkmeyer, 2010, Hospital complication rates with bariatric surgery in Michigan, JAMA, 304, 435, 10.1001/jama.2010.1034 · DOI · Paper page
- Altieri, 2016, Lap band outcomes from 19,221 patients across centers and over a decade within the state of New York, Surg Endosc, 30, 1725, 10.1007/s00464-015-4402-8 · DOI
- Mechanick, 2009, American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient, Obesity (Silver Spring), 17, S1, 10.1038/oby.2009.28 · DOI · Paper page
- Mechanick, 2013, Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery, Obesity (Silver Spring), 21, S1, 10.1002/oby.20461 · DOI · Paper page
- Conason, 2013, Substance use following bariatric weight loss surgery, JAMA Surg, 148, 145, 10.1001/2013.jamasurg.265 · DOI · Paper page
- Bhatti, 2016, Self-harm emergencies after bariatric surgery: a population-based cohort study, JAMA Surg, 151, 226, 10.1001/jamasurg.2015.3414 · DOI · Paper page
- Peterhänsel, 2013, Risk of completed suicide after bariatric surgery: a systematic review, Obes Rev, 14, 369, 10.1111/obr.12014 · DOI · Paper page
- Greenberg, 2009, Behavioral and psychological care in weight loss surgery: best practice update, Obesity (Silver Spring), 17, 880, 10.1038/oby.2008.571 · DOI · Paper page
Cited by
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205
Tirzepatide Once Weekly for the Treatment of Obesity
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206038 · Cited by 3,838
Friedrichsen, M., Breitschaft, A., Tadayon, S., Wizert, A., & Skovgaard, D. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14280 · Cited by 427
O'Kane, M., Parretti, H. M., Pinkney, J., Welbourn, R., Hughes, C. A., Mok, J., Walker, N., Thomas, D., Devin, J., Coulman, K. D., et al. (2020) · Obesity Reviews · doi:10.1111/obr.13087 · Cited by 338
GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice
Samms, R. J., Christe, M. E., Collins, K. A. L., Pirro, V., Droz, B. A., Holland, A. K., Friedrich, J. L., Wojnicki, S., Konkol, D. L., Cosgrove, R., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146353 · Cited by 256
Metadata
- Authors
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-12-16
- Volume
- 43
- Issue
- Supplement_1
- Pages
- S89-S97
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4248239717
- Cited by
- 148
- References
- 60
- FWCI
- 19.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.